tetano
Editor, Senior Moderator
JAAD Case Rep. 2018 Oct 12;4(9):953-955. doi: 10.1016/j.jdcr.2018.07.013. eCollection 2018 Oct.
[h=1]Generalized bullous fixed-drug eruption secondary to the influenza vaccine.[/h] Byrd RC[SUP]1[/SUP], Mournighan KJ[SUP]2[/SUP], Baca-Atlas M[SUP]3[/SUP], Helton MR[SUP]3[/SUP], Sun NZ[SUP]1[/SUP], Siegel MB[SUP]2,[/SUP][SUP]4[/SUP].
[h=3]Author information[/h]
[h=4]KEYWORDS:[/h] EM, erythema multiforme; FDE, fixed drug eruption; GBFDE, generalized bullous fixed drug eruption; SJS, Stevens-Johnson syndrome; TEN, toxic epidermal necrolysis; drug; fixed drug eruption; generalized bullous
PMID: 30364778 PMCID: PMC6197945 DOI: 10.1016/j.jdcr.2018.07.013
Free PMC Article
[h=1]Generalized bullous fixed-drug eruption secondary to the influenza vaccine.[/h] Byrd RC[SUP]1[/SUP], Mournighan KJ[SUP]2[/SUP], Baca-Atlas M[SUP]3[/SUP], Helton MR[SUP]3[/SUP], Sun NZ[SUP]1[/SUP], Siegel MB[SUP]2,[/SUP][SUP]4[/SUP].
[h=3]Author information[/h]
[h=4]KEYWORDS:[/h] EM, erythema multiforme; FDE, fixed drug eruption; GBFDE, generalized bullous fixed drug eruption; SJS, Stevens-Johnson syndrome; TEN, toxic epidermal necrolysis; drug; fixed drug eruption; generalized bullous
PMID: 30364778 PMCID: PMC6197945 DOI: 10.1016/j.jdcr.2018.07.013
Free PMC Article